This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwak, E. J.
Right arrow Articles by Singh, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwak, E. J.
Right arrow Articles by Singh, N.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2004, p. 435-438, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.435-438.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Efficacy of Galactomannan Antigen in the Platelia Aspergillus Enzyme Immunoassay for Diagnosis of Invasive Aspergillosis in Liver Transplant Recipients

Eun Jeong Kwak,1 Shahid Husain,1 Asia Obman,2 Lisa Meinke,2 Janet Stout,2 Shimon Kusne,1 Marilyn M. Wagener,2 and Nina Singh1,2*

Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center,1 Veterans Affairs Medical Center, Pittsburgh, Pennsylvania 152402

Received 28 July 2003/ Returned for modification 29 September 2003/ Accepted 2 October 2003

The utility of galactomannan antigen for diagnosing invasive aspergillosis was evaluated in 154 liver transplant recipients. Sample agreement was 98.5%, and patient specificity was 87%. Galactomannan positivity correlated with mortality, even when controlled for the number of tests performed. Whether galactomannan positivity identifies a subgroup at risk for poor outcome warrants further evaluation.


* Corresponding author. Mailing address: Infectious Disease Section, VA Medical Center, University Dr. C, Pittsburgh, PA 15240. Phone: (412) 688-6179. Fax: (412) 688-6950. E-mail: nis5\|[plus ]\|{at}pitt.edu.


Journal of Clinical Microbiology, January 2004, p. 435-438, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.435-438.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Nguyen, M. H., Jaber, R., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Baz, M., Rand, K. H., Clancy, C. J. (2007). Use of Bronchoalveolar Lavage To Detect Galactomannan for Diagnosis of Pulmonary Aspergillosis among Nonimmunocompromised Hosts. J. Clin. Microbiol. 45: 2787-2792 [Abstract] [Full Text]  
  • Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D., Baz, M., Nguyen, M. H. (2007). Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients. J. Clin. Microbiol. 45: 1759-1765 [Abstract] [Full Text]  
  • Singh, N., Paterson, D. L. (2005). Aspergillus Infections in Transplant Recipients. Clin. Microbiol. Rev. 18: 44-69 [Abstract] [Full Text]  
  • Walsh, T. J., Shoham, S., Petraitiene, R., Sein, T., Schaufele, R., Kelaher, A., Murray, H., Mya-San, C., Bacher, J., Petraitis, V. (2004). Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction. J. Clin. Microbiol. 42: 4744-4748 [Abstract] [Full Text]  
  • Singh, N., Obman, A., Husain, S., Aspinall, S., Mietzner, S., Stout, J. E. (2004). Reactivity of Platelia Aspergillus Galactomannan Antigen with Piperacillin-Tazobactam: Clinical Implications Based on Achievable Concentrations in Serum. Antimicrob. Agents Chemother. 48: 1989-1992 [Abstract] [Full Text]